Latest Forum Topics /
SGX
Last:21.74
-0.14
|
 Post Reply
|
|
SGX
|
||||||
|
PhillipTan
Supreme |
11-Dec-2021 17:56
|
|||||
|
x 0
x 0 Alert Admin |
CGS-CIMB upgrades SGX to ' add' , while RHB cuts TP to $10.30CGS-CIMB Research analysts Andrea Choong and William Tng have upgraded Singapore Exchange (SGX) from " hold" to " add" , with an unchanged target price of $10.40.The analysts believe that SGX' s position as a financial hub in Asia could be boosted through future listings via special purpose acquisition companies (SPACs). " Incremental listing fees from SPAC may not be material for SGX but we believe the progressive listings of tech-related and new economy companies may lift valuations of the broader market over time," they write in a Dec 9 research note. Citing Bloomberg reporting, Choong and Tng highlight that Tikehau Capital, Vertex Holdings and Novo Tellus are amongst the first to apply for a SPAC listing on the SGX, with the aim to raise $200 million via their respective IPOs slated to happen by end-2021. " Apart from a list of regional unicorns such as Carro, Carousell, and Ninja Van that could be likely SPAC targets, we opine that the trio could also target their own portfolio of investee companies. For example, Novo Tellus has Novoflex and Tessolve. Tikehau' s investment portfolio centres in Europe, and Vertex (or Temasek' s) portfolio of non-core investments are numerous," they add. In their research note, Choong and Tng also compared SGX' s SPAC regulations to those around the globe, noting that SGX' s rules are largely aligned with the US. " SGX' s SPAC listing requirements of limiting the sponsor' s promote threshold to 20%, allowing public investors the right of redemption regardless of their voting stance on the business combination, and allowing warrants to be detachable from each ordinary SPAC share are consistent with the market practices in the US," they remark. When compared to Hong Kong, the analysts point out that SGX' s regulations are less rigid, with only professional investors with portfolios of over HK$8 million ($1.4 million) allowed to invest in a SPAC until it has merged with a target company. Meanwhile, RHB Group Research has lowered its target price for SGX from $11.10 to $10.30, despite being sanguine on the company' s growth outlook. " We are positive about SGX' s long-term growth prospects from its latest acquisitions and potential pipeline of ETF, REIT, and SPAC listings. However, we remain concerned about near-term elevated operating expenses due to the consolidation of various acquisitions, before the revenue catches up in the mid-term," writes analyst Shekhar Jaiswal in a Dec 10 research note. Jaiswal points out that management has guided for higher operating expenses over the next 12 to 18 months before revenue catches up and margins recover. In addition to costs, Jaiswal is bearish on SGX' s lower securities trading volumes. " Year-to-date for FY2022 [ending June], total securities market turnover value and securities daily average value stood at $102.7 billion and $1.2 billion, respectively. On an annualised basis for FY2022, this is 13% below our estimates," he comments. To that end, he has cut his FY2022 earnings forecast by 4% to reflect the lower volumes, while raising his FY2023 to FY2024 earnings estimates by 5% each. His lower target price is pegged to a P/E ratio of 23 times, down from 25 times previously. The lower P/E ratio is close to one standard deviation above its historical average and includes an 8% ESG premium, Jaiswal says. He also notes concerns remain among investors on SGX' s intention to introduce a scrip dividend scheme that would allow shareholders to reinvest in SGX' s shares, especially if the scrip dividend is issued at a discount. |
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 13:37
|
|||||
|
x 0
x 0 Alert Admin |
remember this Donovan chap? Shouting for $50 for DBS:)
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
FATABA
Supreme |
03-Dec-2021 13:31
|
|||||
|
x 0
x 0 Alert Admin |
haha, they will tell you ...u expect ALL my reports to be accurate and correct. then he dont need to write any more . ( make ton of $$) further all hv their disclaimer It is only readers that need to be really really careful on all these reports . Dyodd
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 13:25
|
|||||
|
x 0
x 0 Alert Admin |
CPIB or SGX should go after such analysts..I feel
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 13:24
|
|||||
|
x 0
x 0 Alert Admin |
hey, I put a TP of SGX - $100...no timing also! :) $100 rupiah!
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
FATABA
Supreme |
03-Dec-2021 13:20
|
|||||
|
x 0
x 0 Alert Admin |
Goldman never state the timing ...so years later they can be right. Also nver know their real objective ....maybe met / writer rewarded alrdy LOL
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 13:15
|
|||||
|
x 0
x 0 Alert Admin |
hope the company has KPIs. Make too many misjudgments and out they go...else you and me can also me analysts..:)
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
john_ric
Supreme |
03-Dec-2021 12:37
|
|||||
|
x 0
x 0 Alert Admin |
sabo by goldman. sgx reversing big time. |
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
PhillipTan
Supreme |
03-Dec-2021 10:20
|
|||||
|
x 0
x 0 Alert Admin |
Typo errors are always common
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 09:56
|
|||||
|
x 0
x 0 Alert Admin |
analyst at GS anyhow hum tum..
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 09:47
|
|||||
|
x 0
x 0 Alert Admin |
smart..talk down and downgrade to get cheap...
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
03-Dec-2021 09:45
|
|||||
|
x 0
x 0 Alert Admin |
salah..9.3 or 8.3 :)
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
john_ric
Supreme |
02-Dec-2021 10:30
|
|||||
|
x 0
x 0 Alert Admin |
Listen to golman waiting for 8.30. | |||||
| Useful To Me Not Useful To Me | ||||||
|
ahbui8
Master |
02-Dec-2021 09:54
|
|||||
|
x 0
x 0 Alert Admin |
ocbc
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
02-Dec-2021 08:56
|
|||||
|
x 0
x 0 Alert Admin |
Singapore ExchangeSingapore Exchange (SGX) said Wednesday it launched leveraged and inverse products from Phillip Capital Management, with the listing of the Phillip MSCI Singapore Daily (2X) Leveraged and Phillip MSCI Singapore Daily (minus 1x) Inverse Products (L& I products). |
|||||
| Useful To Me Not Useful To Me | ||||||
|
PhillipTan
Supreme |
02-Dec-2021 08:52
|
|||||
|
x 0
x 0 Alert Admin |
SGX launches leveraged and inverse products from Phillip CapitalSingapore Exchange (SGX) said Wednesday it launched leveraged and inverse products from Phillip Capital Management, with the listing of the Phillip MSCI Singapore Daily (2X) Leveraged and Phillip MSCI Singapore Daily (minus 1x) Inverse Products (L& I products).The products will offer both institutional and retail investors capital efficient ways to both leverage and hedge exposure in the Singapore market, SGX said, adding the offerings are the first locally domiciled L& L products listed on SGX. Phillip Capital' s new products provide exposure which is two times and one-time inverse, respectively, the daily return of the MSCI Singapore Index, by investing in and replicating the performance of the SGX MSCI Singapore Free Index Futures (SiMSCI), SGX said. " There is clear demand, especially in Asia, for convenient and amplified access to highly popular indices. With this listing, investors can express market views without having to engage in traditional leverage strategies that require margin monitoring or shorting," Michael Syn, head of equities at SGX, said in the statement. " This aligns with our goal to provide global investors with liquid and efficient investment and risk-management tools, for both long-term investing and tactical use," he said. Linus Lim, director and CEO of Phillip Capital Management, said the products allow investors and traders to take positions on their near-term market outlook, with bullish players able to ride the leveraged product, and bearish ones set to use the inverse product to take advantage of market weakness or hedge their portfolio. |
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
02-Dec-2021 06:45
|
|||||
|
x 0
x 0 Alert Admin |
Singapore Blue Chip Stocks Trading Near 52-Week Lows: Should You Buy?
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
01-Dec-2021 16:07
|
|||||
|
x 0
x 0 Alert Admin |
btw, who' s yr broker? GS?
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
tongphlp
Supreme |
01-Dec-2021 15:47
|
|||||
|
x 0
x 0 Alert Admin |
tks for clarifying
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
ahbui8
Master |
01-Dec-2021 15:41
|
|||||
|
x 0
x 0 Alert Admin |
This was sent by my broker
|
|||||
| Useful To Me Not Useful To Me | ||||||